Skip to main content
. 2023 Jan 6;10:1041586. doi: 10.3389/fpubh.2022.1041586

Table 3.

Vaccine effectiveness (VE) for double doses of the BBV-152 and AZD1222 vaccines.

Vaccination status COVISHIELD (AZD1222) COVAXIN (BBV-152)
Cases Controls VE (95% CI) Adj. VE * (95% CI) Cases Controls VE (95% CI) Adj. VE * (95% CI)
Unvaccinated 713 (57.3) 532 (42.7) Ref. Ref. 713 (57.3) 532 (42.7) Ref. Ref.
Double dose 28 (28.6) 70 (71.4) 70.2% (53.1%−81.0%) 79.0% (65.4%−87.2%) 19 (32.2) 40 (67.8) 65.0% (38.9%−80.0%) 74.0% (50.5%−86.0%)
*

Adjusted for age, sex, and number of comorbidities.